Abbvie said on Friday it would record a charge of about $3.5 billion related to its experimental schizophrenia drug, ...

Despite advances, there remain gaps in the understanding of and personalized treatment for chronic pain in rheumatology, especially among women.

In 2024, the Rx IP Update team at Smart & Biggar reported on a number of developments in Canadian life sciences IP and ...

Nurse-led care effectively reduces disease activity and improves self-efficacy in patients with rheumatoid arthritis, ...